Description
Noopept research nootropic
Noopept (omberacetam) is a synthetic dipeptide-derived compound developed in Russia and often grouped with racetams. It is metabolised to cycloprolylglycine.
Product details
| Compound | Noopept (omberacetam) |
|---|---|
| Class | Dipeptide-derived nootropic (N-phenylacetyl-L-prolylglycine ethyl ester) |
| Form | Tablet; Liquid; Powder; Nasal Spray |
| Strength | 40mg/27ct/1080mg; 40mg/54ct/2160mg; 30ml/167mg per ml/5000mg; 5g; 1mg/spray = 100mg total; 15ml/84mg per m/1260mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Neurotrophic signalling: NGF and BDNF expression in rodents.
- Metabolism: cycloprolylglycine formation.
- Comparative research: potency versus piracetam.
Research interest does not establish a proven effect in humans.
Regulatory status
Noopept is registered in Russia but is not approved by the FDA or EMA. The material sold here is a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Noopept + NAD + Stack · Mirabegron · Urolithin A Powder · All nootropics
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.